guest ::
| Home > Publications database > Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances. |
| Home > Publications database > Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances. |
| Journal Article (Review Article) | DKFZ-2023-00973 |
; ; ; ; ;
2023
Molecular Diversity Preservation International
Basel
This record in other databases: 
Please use a persistent id in citations: doi:10.3390/ijms24097922
Abstract: Colorectal cancer (CRC) is the third most common cancer worldwide, and metastatic CRC is a fatal disease. The CRC-affected tissues show several molecular markers that could be used as a fresh strategy to create newer methods of treating the condition. The liver and the peritoneum are where metastasis occurs most frequently. Once the tumor has metastasized to the liver, peritoneal carcinomatosis is frequently regarded as the disease's final stage. However, nearly 50% of CRC patients with peritoneal carcinomatosis do not have liver metastases. New diagnostic and therapeutic approaches must be developed due to the disease's poor response to present treatment choices in advanced stages and the necessity of an accurate diagnosis in the early stages. Many unique and amazing nanomaterials with promise for both diagnosis and treatment may be found in nanotechnology. Numerous nanomaterials and nanoformulations, including carbon nanotubes, dendrimers, liposomes, silica nanoparticles, gold nanoparticles, metal-organic frameworks, core-shell polymeric nano-formulations, and nano-emulsion systems, among others, can be used for targeted anticancer drug delivery and diagnostic purposes in CRC. Theranostic approaches combined with nanomedicine have been proposed as a revolutionary approach to improve CRC detection and treatment. This review highlights recent studies, potential, and challenges for the development of nanoplatforms for the detection and treatment of CRC.
Keyword(s): Humans (MeSH) ; Nanomedicine: methods (MeSH) ; Peritoneal Neoplasms (MeSH) ; Precision Medicine (MeSH) ; Nanotubes, Carbon (MeSH) ; Gold (MeSH) ; Metal Nanoparticles (MeSH) ; Nanoparticles: therapeutic use (MeSH) ; Colorectal Neoplasms: diagnosis (MeSH) ; Colorectal Neoplasms: drug therapy (MeSH) ; Theranostic Nanomedicine (MeSH) ; Drug Delivery Systems: methods (MeSH) ; cancer therapy ; clinical status ; colorectal cancer ; nanomedicine ; theranostics ; Nanotubes, Carbon ; Gold
; 
; 
; Article Processing Charges ; Clarivate Analytics Master Journal List ; Current Contents - Physical, Chemical and Earth Sciences ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
